Delhi High Court

July 25, 2025
Blog
No Comments

Protecting IP in a Global Market: Delhi HC’s Strategic Use of Section 151 CPC

Introduction The Delhi High Court recently addressed a pressing issue in Communication Components Antenna Inc. v. Ace Technologies Corp. and Ors1: how can Indian patent holders enforce their rights when foreign infringers have no assets in India? The case involved a cross-border patent dispute where the defendants, based in South Korea and Hong Kong, were […]

July 18, 2025
Blog
No Comments

Delhi High Court Reiterates Limits on Patentability of Software-Based Inventions

On July 1, 2025, in Kroll Information Assurance, LLC v. The Controller General of Patents, Designs and Trademarks & Ors.1, the Delhi High Court upheld the refusal of a patent application under Section 3(k) of the Indian Patents Act, 1970, reaffirming that a mere sequence of instructions or abstract profiling logic is insufficient for patent […]

July 18, 2025
Blog
No Comments

Delhi High Court Stays Multimillion Dollar Decree against Amazon

Introduction On July 1, 2025, the Delhi High Court passed a significant order 1staying the execution of a ₹336 crore (approx. USD 38.8 million) decree awarded against Amazon Technologies Inc. in a trademark infringement suit initiated by Lifestyle Equities CV and Lifestyle Licensing BV—entities associated with the Beverly Hills Polo Club (BHPC) brand. This stay […]

July 11, 2025
Blog
No Comments

How Delay and Non-Use Undid Conqueror’s Claims Against Xiaomi

Introduction How Delay and Non-Use Undid Conqueror’s Claims Against Xiaomi The Delhi High Court’s decision in Conqueror Innovations Private Limited & Anr. v. Xiaomi Technology India Private Limited1 [1] offers a meticulous exploration of patent infringement claims and the high threshold required for interim relief in Indian patent litigation. Justice Amit Bansal’s judgment, pronounced on […]

July 11, 2025
Blog
No Comments

A Weighty Dispute: Novo Nordisk’s Semaglutide Patent Clash in Delhi High Court

Introduction A major patent battle [1] has erupted in India between pharmaceutical giants Novo Nordisk and Dr. Reddy’s Laboratories over the popular weight loss and diabetes drug semaglutide. Novo Nordisk sued Dr. Reddy’s for manufacturing and exporting its patented drug without consent. This case is significant for the Indian pharmaceutical industry, as its outcome will […]

June 20, 2025
Blog
No Comments

No Patent For Intermediates without Efficacy

Introduction On May 27, 2025, in Zeria Pharmaceutical Co. Ltd. v. Deputy Controller of Patents and Designs1, the Delhi High Court upheld the refusal of divisional patent, affirming that minor structural modifications of known pharmaceutical compounds—especially intermediates—must still demonstrate enhanced therapeutic efficacy to be patentable under Section 3(d) of the Indian Patents Act, 1970. The […]

June 9, 2025
Blog
No Comments

When Coverage Isn’t Disclosure: DelhiHC’s Denies Interim Injunction forRisdiplam

Introduction On March 25, 2025, the Delhi High Court denied the request of F. Hoffmann-La Roche AG for an interim injunction against Natco Pharma in a high-stakes pharmaceutical patent dispute in F. Hoffmann-La Roche Ag & Anr. vs Natco Pharma Limited [1]1. At issue was Roche’s species patent on “Risdiplam,” a life-saving drug for Spinal […]

May 12, 2025
Blog
No Comments

Trade Secret Protection in India: A Comprehensive Overview

Introduction Trade secrets are crucial to modern business strategy, particularly in sectors driven by innovation, technology, or unique practices. Unlike patents, which require formal registration and public disclosure, trade secrets are protected through confidentiality and non-disclosure agreements (NDAs). In India, the growing importance of trade secret protection is driven by intensifying local and global competition. […]

May 8, 2025
Blog
No Comments

Delhi High Court Reins in Patent Claim Amendments: AbbVie’s Attempt to Convert Method Claims Rejected

Delhi High Court Reins in Patent Claim Amendments: AbbVie’s Attempt to Convert Method Claims Rejected Introduction In a recent judgment in Abbvie Biotherapeutics INC & ANR. v. Assistant Controller of Patents and Designs [1]1, the Delhi High Court upheld the patent refusal order issued by the Controller of Patents for Indian patent application No. 201817047767, […]

April 30, 2025
Blog
No Comments

Analyzing the Draft Computer-Related Inventions (CRI) Guidelines 2025 – Part 5: Determination of Excluded Subject Matter

Introduction This article is the final part of our multi-blog series on analyzing the Draft Computer-Related Inventions (CRI) Guidelines, 2025. Part 1 discusses the new definitions and terms introduced in the Guidelines, Part 2 discusses the judgments referred to in the Guidelines, Part 3 discusses the novelty and inventive step sections and Part 4 discusses […]